Logo image of JBLU

JETBLUE AIRWAYS CORP (JBLU) Stock Fundamental Analysis

NASDAQ:JBLU - Nasdaq - US4771431016 - Common Stock

7.96  +0.32 (+4.19%)

After market: 8.01 +0.05 (+0.63%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to JBLU. JBLU was compared to 23 industry peers in the Passenger Airlines industry. JBLU has a bad profitability rating. Also its financial health evaluation is rather negative. JBLU does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year JBLU has reported negative net income.
In the past year JBLU had a positive cash flow from operations.
In the past 5 years JBLU reported 4 times negative net income.
Of the past 5 years JBLU 4 years had a positive operating cash flow.
JBLU Yearly Net Income VS EBIT VS OCF VS FCFJBLU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B -1B

1.2 Ratios

JBLU's Return On Assets of -5.14% is in line compared to the rest of the industry. JBLU outperforms 43.48% of its industry peers.
JBLU has a Return On Equity (-32.30%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -5.14%
ROE -32.3%
ROIC N/A
ROA(3y)-2.12%
ROA(5y)-2.33%
ROE(3y)-8.06%
ROE(5y)-9.32%
ROIC(3y)N/A
ROIC(5y)N/A
JBLU Yearly ROA, ROE, ROICJBLU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 -20 -30

1.3 Margins

With a decent Gross Margin value of 64.75%, JBLU is doing good in the industry, outperforming 78.26% of the companies in the same industry.
In the last couple of years the Gross Margin of JBLU has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for JBLU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 64.75%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.06%
GM growth 5Y-1.29%
JBLU Yearly Profit, Operating, Gross MarginsJBLU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50

More info and screens

3

2. Health

2.1 Basic Checks

JBLU does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for JBLU has been increased compared to 1 year ago.
The number of shares outstanding for JBLU has been increased compared to 5 years ago.
The debt/assets ratio for JBLU is higher compared to a year ago.
JBLU Yearly Shares OutstandingJBLU Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M
JBLU Yearly Total Debt VS Total AssetsJBLU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B 10B

2.2 Solvency

Based on the Altman-Z score of 0.82, we must say that JBLU is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.82, JBLU is in line with its industry, outperforming 47.83% of the companies in the same industry.
JBLU has a Debt/Equity ratio of 2.98. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 2.98, JBLU perfoms like the industry average, outperforming 43.48% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.98
Debt/FCF N/A
Altman-Z 0.82
ROIC/WACCN/A
WACC6.12%
JBLU Yearly LT Debt VS Equity VS FCFJBLU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B

2.3 Liquidity

A Current Ratio of 1.21 indicates that JBLU should not have too much problems paying its short term obligations.
JBLU has a Current ratio of 1.21. This is amongst the best in the industry. JBLU outperforms 91.30% of its industry peers.
A Quick Ratio of 1.18 indicates that JBLU should not have too much problems paying its short term obligations.
JBLU has a better Quick ratio (1.18) than 91.30% of its industry peers.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 1.18
JBLU Yearly Current Assets VS Current LiabilitesJBLU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

More info and screens

3

3. Growth

3.1 Past

JBLU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1066.67%.
Looking at the last year, JBLU shows a decrease in Revenue. The Revenue has decreased by -3.90% in the last year.
Measured over the past years, JBLU shows a small growth in Revenue. The Revenue has been growing by 4.66% on average per year.
EPS 1Y (TTM)-1066.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.97%
Revenue 1Y (TTM)-3.9%
Revenue growth 3Y48.15%
Revenue growth 5Y4.66%
Sales Q2Q%0.51%

3.2 Future

Based on estimates for the next years, JBLU will show a very strong growth in Earnings Per Share. The EPS will grow by 31.35% on average per year.
Based on estimates for the next years, JBLU will show a small growth in Revenue. The Revenue will grow by 4.19% on average per year.
EPS Next Y-91.17%
EPS Next 2Y-16.03%
EPS Next 3Y25.57%
EPS Next 5Y31.35%
Revenue Next Year-3.34%
Revenue Next 2Y0.76%
Revenue Next 3Y-0.13%
Revenue Next 5Y4.19%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
JBLU Yearly Revenue VS EstimatesJBLU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
JBLU Yearly EPS VS EstimatesJBLU Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

JBLU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for JBLU. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
JBLU Price Earnings VS Forward Price EarningsJBLU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

JBLU's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.19
JBLU Per share dataJBLU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

JBLU's earnings are expected to grow with 25.57% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-16.03%
EPS Next 3Y25.57%

More info and screens

0

5. Dividend

5.1 Amount

JBLU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

JETBLUE AIRWAYS CORP

NASDAQ:JBLU (1/21/2025, 8:09:02 PM)

After market: 8.01 +0.05 (+0.63%)

7.96

+0.32 (+4.19%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)10-29 2024-10-29/bmo
Earnings (Next)01-28 2025-01-28/amc
Inst Owners82.16%
Inst Owner Change0.31%
Ins Owners10.27%
Ins Owner Change2.41%
Market Cap2.76B
Analysts52.17
Price Target6.46 (-18.84%)
Short Float %16.96%
Short Ratio2.91
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)103.75%
Min EPS beat(2)37.94%
Max EPS beat(2)169.56%
EPS beat(4)4
Avg EPS beat(4)64.76%
Min EPS beat(4)18.47%
Max EPS beat(4)169.56%
EPS beat(8)6
Avg EPS beat(8)28.04%
EPS beat(12)8
Avg EPS beat(12)-6.97%
EPS beat(16)12
Avg EPS beat(16)-0.68%
Revenue beat(2)0
Avg Revenue beat(2)-0.81%
Min Revenue beat(2)-0.88%
Max Revenue beat(2)-0.74%
Revenue beat(4)0
Avg Revenue beat(4)-0.91%
Min Revenue beat(4)-1.78%
Max Revenue beat(4)-0.26%
Revenue beat(8)0
Avg Revenue beat(8)-1.47%
Revenue beat(12)0
Avg Revenue beat(12)-1.65%
Revenue beat(16)4
Avg Revenue beat(16)-0.61%
PT rev (1m)0.95%
PT rev (3m)4.42%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-195.18%
EPS NY rev (1m)0%
EPS NY rev (3m)17.39%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.6%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)-0.04%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.3
P/FCF N/A
P/OCF 36.82
P/B 1.04
P/tB 1.23
EV/EBITDA 11.19
EPS(TTM)-0.7
EYN/A
EPS(NY)-0.63
Fwd EYN/A
FCF(TTM)-4.5
FCFYN/A
OCF(TTM)0.22
OCFY2.72%
SpS26.89
BVpS7.62
TBVpS6.49
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.14%
ROE -32.3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 64.75%
FCFM N/A
ROA(3y)-2.12%
ROA(5y)-2.33%
ROE(3y)-8.06%
ROE(5y)-9.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.06%
GM growth 5Y-1.29%
F-Score4
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 2.98
Debt/FCF N/A
Debt/EBITDA 15.8
Cap/Depr 253.1%
Cap/Sales 17.53%
Interest Coverage N/A
Cash Conversion 15.06%
Profit Quality N/A
Current Ratio 1.21
Quick Ratio 1.18
Altman-Z 0.82
F-Score4
WACC6.12%
ROIC/WACCN/A
Cap/Depr(3y)178.75%
Cap/Depr(5y)180.86%
Cap/Sales(3y)13.03%
Cap/Sales(5y)16.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1066.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.97%
EPS Next Y-91.17%
EPS Next 2Y-16.03%
EPS Next 3Y25.57%
EPS Next 5Y31.35%
Revenue 1Y (TTM)-3.9%
Revenue growth 3Y48.15%
Revenue growth 5Y4.66%
Sales Q2Q%0.51%
Revenue Next Year-3.34%
Revenue Next 2Y0.76%
Revenue Next 3Y-0.13%
Revenue Next 5Y4.19%
EBIT growth 1Y-240.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year511.05%
EBIT Next 3Y121.27%
EBIT Next 5Y93.75%
FCF growth 1Y-167.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-63.94%
OCF growth 3YN/A
OCF growth 5Y-19.73%